A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy.

Gebbia, V

A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. [electronic resource] - Anticancer research - 731-4 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0250-7005


Adult
Aged
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Endometrial Neoplasms--drug therapy
Female
Fever--prevention & control
Granulocyte Colony-Stimulating Factor--adverse effects
Head and Neck Neoplasms--drug therapy
Humans
Incidence
Lung Neoplasms--drug therapy
Male
Middle Aged
Mycoses--epidemiology
Neoplasms--drug therapy
Neutropenia--epidemiology
Ovarian Neoplasms--drug therapy
Prospective Studies
Stomach Neoplasms--drug therapy
Thymopentin--adverse effects